Sylvia Kang
Sylvia is committed to bringing point-of-care technology to improve consumers’ health. She has significant P&L general management experiences. Sylvia has taken business and product director roles in a Fortune 500 life science company, running a $100M global business. Holds an MBA from Cornell University, and a MS in Biomedical Engineering from Columbia University.
Co-founder and CEO of Mira, the first FDA and CE registered comprehensive women’s health home monitoring platform with more than 60,000 users across the globe. Mira measures key fertility hormones (LH, E3G and PdG) in the urine and provides easy-to-understand numeric values of these hormones.
Co-founder and CEO of Mira, the first FDA and CE registered comprehensive women’s health home monitoring platform with more than 60,000 users across the globe. Mira measures key fertility hormones (LH, E3G and PdG) in the urine and provides easy-to-understand numeric values of these hormones.